Following the newly published positive Phase III delayed study (ADAGIO) with rasagiline in Parkinson's Disease, this volume presents 15 papers on various aspects of Monoamine Oxidase and its Inhibitors.
Pharmacology of selegiline
Xray crystal structure of MAO A and B
Structures of MAO A and B. Deficit of MAO clinical implications
Pharmacology of MAO and B inhbitors and Cheese reaction
Safinamide. Novel reversible MAO B.
Ladostigil amd M30in PD and AD neuroprotection and
neurorestoration.
Rasagline and disease modification
Rasagiline and Parkinson's disease and neuroprotection
Multimodal drugs and their future for AD and PD
Molecular mechanism of selegiline as a neuroprotectiev drug
Kinetics of monoamine oxidase
novel MAO inhibitors
Rasagiline in Parkinson’s disease
"Invaluable reading." --NATURE
"A valuable addition to any library as current reference material
for advanced undergraduates, graduate students, and professional
scientists." --CHOICE
Ask a Question About this Product More... |